Get started
Author

Rakesh Kore

Observed names: Rakesh K Kore, Rakesh Kumar Kore
Observed institution: Guru Ghasidas Vishwavidyalaya
ORCID: 0000-0002-4093-4487
Observed ORCID: 0000-0002-4093-4487
OpenAlex ID: A5071896014
Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective
2022 · Vijay K. Patel, Ekta Shirbhate, et al. · Current Medicinal Chemistry · 47
Microbial Metabolites-induced Epigenetic Modifications for Inhibition of Colorectal Cancer: Current Status and Future Perspectives
2024 · Vaibhav Singh, Ekta Shirbhate, et al. · Mini-Reviews in Medicinal Chemistry · 22
Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
2023 · Vijay K Patel, Aayush Vaishnaw, et al. · Mini-Reviews in Medicinal Chemistry · 18
Combination Therapy for the Treatment of Alzheimer’s Disease: Recent Progress and Future Prospects
2022 · Ekta Shirbhate, Vijay K. Patel, et al. · Current Topics in Medicinal Chemistry · 18
Synergistic strategies: histone deacetylase inhibitors and platinum-based drugs in cancer therapy
2025 · Ekta Shirbhate, Vaibhav Singh, et al. · Expert Review of Anticancer Therapy · 7
Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer
2024 · Vaibhav Singh, Ekta Shirbhate, et al. · Mini-Reviews in Medicinal Chemistry · 7
New Investigational Drug’s Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects
2024 · Rakesh Kumar Kore, Ekta Shirbhate, et al. · Cancer Investigation · 5
The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance
2024 · Ekta Shirbhate, Vaibhav Singh, et al. · Current Topics in Medicinal Chemistry · 4
Epigenetic–Genetic Crosstalk at the Cancer–Diabetes Interface: Convergent Molecular Pathways, Multi‐Omics Biomarkers, and Dual Therapeutic Targets
2026 · Vaibhav Singh, Ekta Shirbhate, et al. · The FASEB Journal · 1
Mitochondrial Dynamics and Bioenergetic Reprogramming: Drivers of Cancer Therapy Resistance
2026 · Varsha Johariya, Vaibhav Singh, et al. · Mini-Reviews in Medicinal Chemistry
Regulatory and Ethical Considerations in Plant-Based Nanomedicine
2026 · Subham K. Vishwakarma, Vaibhav Singh, et al. · CRC Press eBooks
Apolipoprotein E and precision medicine: Individualized disease management approaches
2026 · Vaibhav Singh, Ekta Shirbhate, et al. · Elsevier eBooks
Targeting Microbiome-Derived Exosomes to Overcome Cancer Therapy Resistance: Mechanisms, Implications, and Opportunities
2025 · Vaibhav Singh, Ekta Shirbhate, et al. · Mini-Reviews in Medicinal Chemistry
Memantine and Glutamate Antagonists in the Treatment of Alzheimer's Disease: Current Updates
2023 · Rakesh Kore, Priya Tiwari, et al. · BENTHAM SCIENCE PUBLISHERS eBooks
Works count: 15
Citation count: 129
H-index: 6
I10-index: 4
Year
Topic
Type